Griseofulvin: a new look at an old drug.
 Griseofulvin is the oral antifungal agent of choice for the treatment of dermatophytoses.
 This article reviews the history, pharmacokinetics, adverse reactions, and traditional therapeutic applications of griseofulvin.
 In addition, reports since 1960 of the use of the drug in the treatment of Raynaud's phenomenon, progressive systemic sclerosis, lichen planus, mycosis fungoides, herpes zoster, eosinophilic fasciitis, and molluscum contagiosum are discussed, noting the varying degree of therapeutic success.
